Skin Cancer / Melanoma
For further information please follow the links to individual researcher profiles:
| Dr Fiona Bath-Hextall |
Non Melanoma Skin Cancer (NMSC); focusing on interventions for the treatment of NMSC; interventions for improving knowledge of skin cancer and risk factors of skin cancer such as smoking and arsenic |
| Prof Poulam Patel |
Kidney cancer; malignant melanoma; clinical trials in cancer; cancer vaccines; dendritic cell biology; host tumour interactions |
| Prof Lindy Durrant |
Engineering Antibodies for Cancer Therapy; NUTAC (Nottingham University Therapeutic Antibody Centre); Cancer Vaccine Design |
| Dr Andrew Jackson |
Influence of tumour microenvironment on dendritic cells and macrophage; intracellular signalling pathways of APC and polarisation of T-cell responses; immunoregulatory role of ER-stress responses; cancer vaccines |
| Dr Louise Lansbury |
Treatment of the second most common skin cancer: Squamous Cell Carcinoma of the skin |
|
Dr Srinivasan Madhusudan
|
DNA repair; base excision repair; APE1 inhibitors; stratified medicine; cancer clinical trials |
| Dr Stewart Martin |
Prognostic and predictive biomarkers; lymphatic biology and metastasis; radiation biology/radiotherapy; calpains and calpastatin |
| Dr Ioan Notingher |
Development of new optical and spectroscopic methods for studying biological materials at a nano and micro-scale; understanding the interaction of cells with cancer drugs |
| Prof Hywel Williams |
Clinical trials; systematic reviews; epidemiology of atopic eczema |